Expanded Access for Hereditary Angioedema (HAE)

Trial Profile

Expanded Access for Hereditary Angioedema (HAE)

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Complement C1 inhibitor protein (Primary)
  • Indications Hereditary angioedema
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 27 Jul 2017 Status changed from recruiting to completed.
    • 08 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top